Company profile ARVN
After 39 days of this quarter the interest is at 94.0. Based on that we can calculate that during remaining 52 days it will total up to 219.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 93 | 164 76.3% QoQ | 146 -11.0% QoQ | 133 -8.9% QoQ |
| 2020 | 130 39.8% YoY -2.3% QoQ | 188 14.6% YoY 44.6% QoQ | 114 -21.9% YoY -39.4% QoQ | 234 75.9% YoY 105.3% QoQ |
| 2021 | 160 23.1% YoY -31.6% QoQ | 143 -23.9% YoY -10.6% QoQ | 208 82.5% YoY 45.5% QoQ | 197 -15.8% YoY -5.3% QoQ |
| 2022 | 207 29.4% YoY 5.1% QoQ | 216 51.0% YoY 4.3% QoQ | 196 -5.8% YoY -9.3% QoQ | 221 12.2% YoY 12.8% QoQ |
| 2023 | 259 25.1% YoY 17.2% QoQ | 209 -3.2% YoY -19.3% QoQ | 185 -5.6% YoY -11.5% QoQ | 248 12.2% YoY 34.1% QoQ |
| 2024 | 94 -63.7% YoY -62.1% QoQ | - | - | - |
The average 5 years interest of Arvinas was 14.35 per week. The last year interest of Arvinas compared to the last 5 years has changed by 18.19%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 47.99%.
There is not enough data for Arvinas clinical trials to provide analysis
There is not enough data for Arvinas clinical trials to provide correlation calculation
There is not enough data for Arvinas clinical trials to provide analysis
There is not enough data for Arvinas PROTAC to provide analysis
There is not enough data for Arvinas PROTAC to provide correlation calculation
There is not enough data for Arvinas PROTAC to provide analysis
There is not enough data for Arvinas prostate cancer to provide analysis
There is not enough data for Arvinas prostate cancer to provide correlation calculation
There is not enough data for Arvinas prostate cancer to provide analysis
There is not enough data for Arvinas breast cancer to provide analysis
There is not enough data for Arvinas breast cancer to provide correlation calculation
There is not enough data for Arvinas breast cancer to provide analysis
There is not enough data for Arvinas Pfizer collaboration to provide analysis
There is not enough data for Arvinas Pfizer collaboration to provide correlation calculation
There is not enough data for Arvinas Pfizer collaboration to provide analysis
There is not enough data for Arvinas Genentech collaboration to provide analysis
There is not enough data for Arvinas Genentech collaboration to provide correlation calculation
There is not enough data for Arvinas Genentech collaboration to provide analysis
There is not enough data for Arvinas F. Hoffman-La Roche collaboration to provide analysis
There is not enough data for Arvinas F. Hoffman-La Roche collaboration to provide correlation calculation
There is not enough data for Arvinas F. Hoffman-La Roche collaboration to provide analysis
After 39 days of this quarter the interest is at 40.0. Based on that we can calculate that during remaining 52 days it will total up to 93.0. Arvinas news expected interest is significantly higher compared to same quarter last year (+220.7%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 78 | 67 -14.1% QoQ | 50 -25.4% QoQ | 35 -30.0% QoQ |
| 2020 | 76 -2.6% YoY 117.1% QoQ | 0 -100.0% YoY -100.0% QoQ | 67 34.0% YoY inf% QoQ | 146 317.1% YoY 117.9% QoQ |
| 2021 | 67 -11.8% YoY -54.1% QoQ | 0 -11.8% YoY -100.0% QoQ | 162 141.8% YoY inf% QoQ | 18 -87.7% YoY -88.9% QoQ |
| 2022 | 37 -44.8% YoY 105.6% QoQ | 14 inf% YoY -62.2% QoQ | 61 -62.3% YoY 335.7% QoQ | 81 350.0% YoY 32.8% QoQ |
| 2023 | 29 -21.6% YoY -64.2% QoQ | 187 1235.7% YoY 544.8% QoQ | 18 -70.5% YoY -90.4% QoQ | 67 -17.3% YoY 272.2% QoQ |
| 2024 | 40 37.9% YoY -40.3% QoQ | - | - | - |
The average 5 years interest of Arvinas news was 4.98 per week. The last year interest of Arvinas news compared to the last 5 years has changed by 20.48%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 35.75%.
After 92 days of this quarter the interest is at 142.0. Based on that we can calculate that during remaining 0 days it will total up to 142.0. Arvinas stock price expected interest is significantly higher compared to previous quarter (+75.3%) and same quarter last year (+115.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 56 |
| 2019 | 214 282.1% QoQ | 17 -92.1% QoQ | 63 270.6% QoQ | 123 119.6% YoY 95.2% QoQ |
| 2020 | 17 -92.1% YoY -86.2% QoQ | 34 100.0% YoY 100.0% QoQ | 81 28.6% YoY 138.2% QoQ | 98 -20.3% YoY 21.0% QoQ |
| 2021 | 87 411.8% YoY -11.2% QoQ | 42 23.5% YoY -51.7% QoQ | 120 48.1% YoY 185.7% QoQ | 59 -39.8% YoY -50.8% QoQ |
| 2022 | 19 -78.2% YoY -67.8% QoQ | 68 61.9% YoY 257.9% QoQ | 66 -45.0% YoY -2.9% QoQ | 264 347.5% YoY 300.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 81 19.1% YoY inf% QoQ | 142 115.2% YoY 75.3% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Arvinas stock price was 6.35 per week. The last year interest of Arvinas stock price compared to the last 5 years has changed by 47.56%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 33.1%.